Navigation Links
Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
Date:10/29/2007

Application of ZFN Technology in Stem Cells has Potential to Yield High

Value Research Reagents and Therapeutic Products

ST. LOUIS and RICHMOND, Calif., Oct. 29 /PRNewswire-FirstCall/ -- Sigma-Aldrich Corporation (Nasdaq: SIAL) and Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today the publication of data demonstrating the use of Sangamo's ZFP Nucleases (ZFNs) for "gene-editing" in human stem cells. This work represents a significant advance in the ability to specifically and efficiently modify the human genome in stem cells potentially enabling the efficient generation of stem cell lines for use as models of human disease for medical research and for drug testing. In addition to its use in the generation of valuable research reagents, the technology has potential in the therapeutic application of stem cells.

The work, which was carried out in the laboratory of Luigi Naldini, M.D., Ph.D. at the San Raffaele Telethon Institute for Gene Therapy, Milan, Italy, in collaboration with Sangamo scientists, was published in Nature Biotechnology as an advance online publication (http://www.nature.com/nbt/journal/vaop/ncurrent/abs/nbt1353.html).

"This is a significant advance for both research and the potential therapeutic use of stem cells," stated Dr. Naldini, a senior author of the study. "Stem cells are the body's natural resource for regeneration and re
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Sangamo BioSciences Announces Presentation of Phase 1 ZFP Therapeutic Data at American Diabetes Association Meeting
2. Sangamo BioSciences Announces Presentation of ZFP Therapeutic Data From Nerve Regeneration Program at American Society for Neural Therapy and Repair Meeting
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
4. YM BioSciences Announces Preclinical Data Confirming Nimotuzumab Binds to the EGF Receptor and Potentiates Radiotherapy
5. Neurocrine Biosciences Announces New Research Studies Presented at APSS Reveal Significant Under-Diagnosis of Insomnia
6. Hana Biosciences Presents Data On Two Programs At the American Society of Clinical Oncology Annual Meeting
7. IR BioSciences Announces Promising Data from Study of Its Compound Homspera
8. Lux Biosciences Investigational Therapy for Uveitis, LX211, is Subject of Two Presentations at Key Ophthalmology Meeting, ARVO 2007
9. YM BioSciences Reports AeroLEF Randomized Phase IIb Trial Meets Primary Endpoint in Patients with Post-Surgical Pain
10. Hana Biosciences Announces Data to be Presented On Talvesta (Talotrexin) for Injection at The American Association for Cancer Research Annual Meeting
11. Ace Biosciences, Ace393, the Worlds First Commercial Vaccine for Travellers Diarrhoea Caused by Campylobacter Successfully Completes Phase I Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 2014  Seres Health, a clinical-stage therapeutics company ... human microbiome, announced today that Dr. David ... and Chief Scientific Officer, will be presenting at ... Chemotherapy (ICAAC). The presentation will highlight the scientific ... of bacterial spores derived from the human microbiome, ...
(Date:8/28/2014)... 28, 2014   Venaxis, Inc.  (Nasdaq:  APPY), an ... FDA clearance for and commercializing its CE Marked ... in identifying children, adolescent, and young adult patients in ... appendicitis, today announced it will present at three upcoming ... Annual Global Investment Conference being held in ...
(Date:8/28/2014)... Pa. , Aug. 28, 2014  Robotic ... patients, and media, both for the promise of ... safety. The quick deployment of surgical robots and ... are prompting facilities to evaluate their robotic surgery ... entire surgical team.    ECRI Institute ...
Breaking Medicine Technology:Seres Health to Present Clinical Findings at ICAAC 2014 Conference 2Venaxis to Present at September Investor Conferences 2Venaxis to Present at September Investor Conferences 3Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 2Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 3Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 4Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 5
... shows one in five sisters of a primary ... ROCHESTER, Minn., Sept. 10 Mayo Clinic,researchers ... of patients with primary biliary cirrhosis (PBC) are,more ... in their blood. Armed with,this new information, physicians ...
... The following letter is,being released by CEL-SCI CORPORATION (Amex: ... Shareholders: The past 12 months have been the ... Drug Administration (FDA) granted us the go-,ahead for a ... drug,Multikine(R) and also granted Multikine Orphan drug designation. Following,the ...
Cached Medicine Technology:New Research May Lead to Earlier Diagnosis and Treatment of Primary Biliary Cirrhosis in Families 2CEL-SCI Corporation Releases Letter to Shareholders 2CEL-SCI Corporation Releases Letter to Shareholders 3CEL-SCI Corporation Releases Letter to Shareholders 4CEL-SCI Corporation Releases Letter to Shareholders 5
(Date:8/28/2014)... VA (PRWEB) August 28, 2014 Starting ... (Meso Foundation) is able to accept donations in Bitcoin, ... The Bitcoin donation page can be found at ... are accepting Bitcoin as a form of payment, we ... same,” said Meso Foundation’s chief executive officer, Melinda Kotzian. ...
(Date:8/28/2014)... August 29, 2014 UWDress.com, an internationally ... has recently unveiled its fashionable assortment of fall ... all new and old customers, the company is now ... , The company’s discounted fall bridesmaid outfits are offered ... the new collection are priced less than $190. UWDress.com’s ...
(Date:8/28/2014)... HORNE LLP has laid out the challenge ... $67 million firm has more than feel-good emotions at ... the balance. , Described by experts in the accounting ... Baby Boomers creating succession issues, poor leadership development strategies, ... culture wars within firms that are threatening the life ...
(Date:8/28/2014)... about the chance of ,overdiagnosis, through the NHS breast ... according to research published in the British Journal ... survey of around 2,200 women, Cancer Research UK scientists ... cent felt they fully understood the information given about ... cancers that would never have gone on to cause ...
(Date:8/28/2014)... Lake Worth, FL (PRWEB) August 28, 2014 ... promote National Recovery Month throughout September. This month ... of addiction treatment and mental health services. Along ... Millennium Treatment Group is helping to spread the ... Month began in 1989, honoring the work of ...
Breaking Medicine News(10 mins):Health News:Cancer Research Funding Organization Now Accepts Bitcoin Donations 2Health News:Fashionable Fall Bridesmaid Dresses From UWDress.com 2Health News:HORNE LLP Proclaims War on Accounting Firm Culture 2Health News:Some women still don't underststand 'overdiagnosis' risk in breast screening 2Health News:Millennium Treatment Group Celebrates National Recovery Month 2
... expert says, , MONDAY, July 20 (HealthDay News) -- ... of people with leukemia and other serious diseases might ... , Researchers looked at the association between the use ... "IVIg has been used safely for more than 20 ...
... , NEW YORK, July 20 Cancer Care ... multiple myeloma. Cancer Care ,s program will provide individual grants of up to ... and taxi, bus or train fare to and from their medical care. ... by a generous grant from Millennium: The Takeda Oncology Company. Cancer Care ...
... treatment of disease ,The team, led by ... at the University of Copenhagen and the Max Planck Institute ... 1,750 different proteins. "This is more than just ... known acetylation switches by a factor of six, and it ...
... of a new study of the pen and paper ... medical record system may help make electronic medical records ... they serve. "Exploring the Persistence of Paper with ... issue of the International Journal of Medical Informatics ...
... , CARY, Ill., July 20 Sage Products, Inc. has ... No. 5 on the list of the Best Medium Sized Companies to ... the Society for Human Resource Management (SHRM). Sage is a veteran-owned company ... on prevention and solving challenges in the healthcare industry. , ...
... , , ... Competition between employer-based health insurance plans and a government-sponsored public ... the majority of employers responding to a Health Care Reform Survey, ... Aon Corporation (NYSE: AOC ). What will help ...
Cached Medicine News:Health News:New Alzheimer's Treatment Could Be on the Horizon 2Health News:New Alzheimer's Treatment Could Be on the Horizon 3Health News:CancerCare Launches New Program to Help Multiple Myeloma Patients Cover Transportation Costs 2Health News:CancerCare Launches New Program to Help Multiple Myeloma Patients Cover Transportation Costs 3Health News:Can pen and paper help make electronic medical records better? 2Health News:Sage Products Named a Top Five Medium Sized Company to Work For In America 2Health News:Sage Products Named a Top Five Medium Sized Company to Work For In America 3Health News:Sage Products Named a Top Five Medium Sized Company to Work For In America 4Health News:Employers Express Doubts About Employer Mandate and Government-Sponsored Public Plan, Says Aon Consulting Survey 2Health News:Employers Express Doubts About Employer Mandate and Government-Sponsored Public Plan, Says Aon Consulting Survey 3Health News:Employers Express Doubts About Employer Mandate and Government-Sponsored Public Plan, Says Aon Consulting Survey 4Health News:Employers Express Doubts About Employer Mandate and Government-Sponsored Public Plan, Says Aon Consulting Survey 5
... Many special order products are offered as ... long lengths. The modular instruments may be ... options such as ratchets, insulation and flush ... Mediflex stock. Customer specifications may affect delivery ...
... are offered as 1-piece or modular, in ... instruments may be customized with handles of ... insulation and flush ports. Many standard patterns ... may affect delivery times. , Please ...
... Many special order products are offered as ... long lengths. The modular instruments may be ... options such as ratchets, insulation and flush ... Mediflex stock. Customer specifications may affect delivery ...
... Many special order products are offered as ... long lengths. The modular instruments may be ... options such as ratchets, insulation and flush ... Mediflex stock. Customer specifications may affect delivery ...
Medicine Products: